Ox-LDL R-1 Antibodies

Santa Cruz Biotechnology delivers a wide array of Ox-LDL R-1 monoclonal antibodies for advanced research in cardiovascular health and disease. Oxidized low-density lipoprotein receptor 1 (Ox-LDL R-1) monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Oxidized low-density lipoprotein receptor 1 (Ox-LDL R-1) plays a central role in the uptake of oxidized LDL, which is implicated in the development of atherosclerosis and other cardiovascular diseases. Understanding Oxidized low-density lipoprotein receptor 1 (Ox-LDL R-1) function is essential for elucidating the mechanisms of lipid metabolism and inflammation in vascular biology. Research focused on Oxidized low-density lipoprotein receptor 1 (Ox-LDL R-1) can reveal potential therapeutic targets for preventing and treating cardiovascular conditions. Investigating the molecular pathways involving Oxidized low-density lipoprotein receptor 1 (Ox-LDL R-1) helps researchers better understand the progression of cardiovascular diseases. Exploring the relationship between Oxidized low-density lipoprotein receptor 1 (Ox-LDL R-1) and various cardiovascular conditions enables the development of targeted therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing cardiovascular research and developing innovative therapeutic approaches.